Takeda Pharmaceutical Balance Sheet Health
Financial Health criteria checks 3/6
Takeda Pharmaceutical has a total shareholder equity of ¥6,921.6B and total debt of ¥5,051.2B, which brings its debt-to-equity ratio to 73%. Its total assets and total liabilities are ¥14,573.0B and ¥7,651.4B respectively. Takeda Pharmaceutical's EBIT is ¥653.6B making its interest coverage ratio 6.7. It has cash and short-term investments of ¥859.0B.
Key information
73.0%
Debt to equity ratio
JP¥5.05t
Debt
| Interest coverage ratio | 6.7x |
| Cash | JP¥859.02b |
| Equity | JP¥6.92t |
| Total liabilities | JP¥7.65t |
| Total assets | JP¥14.57t |
Recent financial health updates
Here's Why Takeda Pharmaceutical (TSE:4502) Can Manage Its Debt Responsibly
Nov 25
Takeda Pharmaceutical (TSE:4502) Takes On Some Risk With Its Use Of Debt
Jun 11Recent updates
Here's Why Takeda Pharmaceutical (TSE:4502) Can Manage Its Debt Responsibly
Nov 25Results: Takeda Pharmaceutical Company Limited Exceeded Expectations And The Consensus Has Updated Its Estimates
Nov 04Takeda Pharmaceutical (TSE:4502) Is Increasing Its Dividend To ¥98.00
Sep 24Why Investors Shouldn't Be Surprised By Takeda Pharmaceutical Company Limited's (TSE:4502) P/E
Sep 20Takeda Pharmaceutical's (TSE:4502) Upcoming Dividend Will Be Larger Than Last Year's
Aug 08Earnings Beat: Takeda Pharmaceutical Company Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Aug 02Takeda Pharmaceutical (TSE:4502) Is Increasing Its Dividend To ¥98.00
Jul 25Takeda Pharmaceutical's (TSE:4502) Upcoming Dividend Will Be Larger Than Last Year's
Jul 11Takeda Pharmaceutical Company Limited (TSE:4502) Yearly Results: Here's What Analysts Are Forecasting For This Year
Jun 30Takeda Pharmaceutical (TSE:4502) Takes On Some Risk With Its Use Of Debt
Jun 11Some Investors May Be Willing To Look Past Takeda Pharmaceutical's (TSE:4502) Soft Earnings
May 21Takeda Pharmaceutical Company Limited Just Recorded A 6.0% EPS Beat: Here's What Analysts Are Forecasting Next
May 12Takeda Pharmaceutical (TSE:4502) Is Due To Pay A Dividend Of ¥94.00
Mar 28Takeda Pharmaceutical (TSE:4502) Has Announced A Dividend Of ¥94.00
Mar 13Takeda Pharmaceutical (TSE:4502) Will Pay A Dividend Of ¥94.00
Feb 26Financial Position Analysis
Short Term Liabilities: 4502's short term assets (¥3,054.0B) exceed its short term liabilities (¥2,387.2B).
Long Term Liabilities: 4502's short term assets (¥3,054.0B) do not cover its long term liabilities (¥5,264.2B).
Debt to Equity History and Analysis
Debt Level: 4502's net debt to equity ratio (60.6%) is considered high.
Reducing Debt: 4502's debt to equity ratio has reduced from 103.2% to 73% over the past 5 years.
Debt Coverage: 4502's debt is not well covered by operating cash flow (17.3%).
Interest Coverage: 4502's interest payments on its debt are well covered by EBIT (6.7x coverage).